If I were looking at a company to decide whether to invest, and saw that they had 5 clinical trials going for 3 different drugs, but their market cap was around 100 million (as it was until very recently), I would assume that there was some horrendous problem with toxic financing or incompetent management, and would not bother to find out what the problem was. Or maybe I'd do a Google search, read the Mako headline, and conclude that the company must be a fraud that was lying about the pipeline -- because how many people are directed to the Mako article first, and NOT the articles showing that the Mako business was an attack by an avowed short, and that the Rosen suit was thrown out with prejudice?

So I think that if you want to attract new investors, it's an excellent thing to say
"The company was attacked by an avowed short-seller but was vindicated by a Federal court, and has proceeded with clinical trials without having to take toxic financing."

I'd suggest adding THAT to AlanC's daily number.